Instituto de Biomedicina de Sevilla -ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2024

  1. Novel insights into metabolic-associated steatotic liver disease preclinical models

    Liver International, Vol. 44, Núm. 3, pp. 644-662

2023

  1. Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for intervention

    BMJ

2022

  1. Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 724-734

2021

  1. Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases

    Frontiers in Immunology, Vol. 12

2018

  1. miR-7 Modulates hESC Differentiation into Insulin-Producing Beta-like Cells and Contributes to Cell Maturation

    Molecular Therapy - Nucleic Acids, Vol. 12, pp. 463-477

2014

  1. GATA4 loss in the septum transversum mesenchyme promotes liver fibrosis in mice

    Hepatology, Vol. 59, Núm. 6, pp. 2358-2370